Mapping Polymorphic Behavior of Process Intermediates, an Often-Overlooked Exercise
- 1 March 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 26 (4) , 1258-1267
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Discovery of GS-9688 (Selgantolimod) as a Potent and Selective Oral Toll-Like Receptor 8 Agonist for the Treatment of Chronic Hepatitis BJournal of Medicinal Chemistry, 2020
- Use of Twin Screw Extruders as a Process Chemistry Tool: Application of Mechanochemistry To Support Early Development ProgramsOrganic Process Research & Development, 2018
- Polymorphism and properties of ammonium scandium sulfate (NH4)3Sc(SO4)3: new intermediate compound in scandium productionCrystEngComm, 2018
- Appearance of a New Hydrated Form during Development: A Case Study in Process and Solid-State OptimizationOrganic Process Research & Development, 2015
- Selection of a Suitable Physical Form and Development of a Crystallization Process for a PDE10A Inhibitor Exhibiting Enantiotropic PolymorphismOrganic Process Research & Development, 2015
- Development of a Suitable Physical Form for a Sphingosine-1-phosphate Receptor AgonistOrganic Process Research & Development, 2011
- Development of a Suitable Salt Form for a GPR40 Receptor AgonistOrganic Process Research & Development, 2010
- Estimation of the transition temperature for an enantiotropic polymorphic system from the transformation kinetics monitored using Raman spectroscopyJournal of Pharmaceutical and Biomedical Analysis, 2007
- On the polymorphism of pharmaceuticals and other molecular crystals. IIMicrochimica Acta, 1979
- Polymorphism and Drug AvailabilityJournal of Pharmaceutical Sciences, 1963